NAC and Glycine (GlyNAC): Can You Take Them Together?

Glutathione (GSH) is a tripeptide assembled from three amino acids — glutamate, cysteine, and glycine — by two ATP-dependent enzymes operating in sequence. Gamma-glutamylcysteine ligase first joins glutamate to cysteine, then glutathione synthetase adds glycine to complete the molecule. NAC (N-acetylcysteine) serves as the delivery vehicle for cysteine, which is traditionally considered the single rate-limiting substrate because free cysteine is unstable in the bloodstream and rapidly oxidizes. However, the designation of cysteine as the sole bottleneck is incomplete. Glycine availability also limits glutathione production, particularly during aging when endogenous glycine synthesis declines by an estimated 15-25% between ages 40 and 70. When glycine supply drops, glutathione synthetase cannot complete the final assembly step regardless of how much cysteine is available. Supplementing NAC alone addresses only one bottleneck; adding glycine removes the second, allowing the full biosynthetic pathway to operate at maximum capacity.

Clinical trials from Baylor College of Medicine tested the GlyNAC combination in older adults (ages 61-80) and measured the impact on glutathione levels, oxidative stress markers, and functional outcomes. Participants receiving GlyNAC (NAC 1200mg + glycine 1200mg daily) for 24 weeks showed glutathione concentrations restored to levels comparable to young adults, along with improvements in mitochondrial fatty acid oxidation, reduced markers of systemic inflammation (interleukin-6 and TNF-alpha), improved insulin sensitivity, reduced genomic damage, and increased grip strength. Notably, these benefits reversed within 12 weeks of stopping supplementation, confirming that the improvements depended on sustained substrate availability rather than a one-time correction. The magnitude of improvement exceeded what NAC alone typically achieves in comparable populations, demonstrating that glycine co-supplementation addresses a genuine physiological bottleneck rather than providing redundant substrate. This dual-substrate approach represents a shift from the traditional NAC-only paradigm toward a more complete glutathione support strategy.